Mechanisms associated with organotropic metastasis

与器官转移相关的机制

基本信息

  • 批准号:
    10295926
  • 负责人:
  • 金额:
    $ 51.01万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-07-01 至 2026-06-30
  • 项目状态:
    未结题

项目摘要

ABSTRACT Most cancer patients with solid tumors die of metastatic disease and organotropic spread is an understudied aspect of metastasis, for which new insights are urgently required. The prevailing ‘seed and soil’ concept posits that permissive environment in a distant organ (soil) is necessary to support the survival and growth of lurking tumor cells (seeds). Induction of permissive soil in a non-metastatic organ is proposed to re-route metastasis; however, rigorous experimental evidence and mechanistic analyses are lacking. Fibrotic tissue alterations, including inflammation, provide cues for metastasis, together with the signals from bone marrow-derived cells (BMDCs), the tumor secretome, and circulating extracellular vesicles. Our preliminary data suggest organotropic metastasis is not solely dependent on permissive matrix remodeling and BMDCs in the secondary organs, but is also contingent on the disruption of vascular endothelial barrier function imposed by organ-specific vascular junction proteins. Our findings lead to a central hypothesis that ‘vascular heterogeneity functionally contributes to organotropism of metastasis’. We propose studies to unravel the mechanisms, by which distinct fibrotic niches effect organ-specific changes in the vascular beds, leading to organotropic metastasis. Preliminary studies identified angiopoetin-2 (Ang-2) as a putative mediator of lung metastasis. We aim to unravel the mechanisms of Ang-2 dependent tropism to the lung but not the kidney or liver, which also generate high Ang-2 levels in the fibrotic setting. Using single-cell RNAseq and CyTOF, we will determine the cellular and molecular targets of Ang-2 in the pre-metastatic milieu. Preliminary studies show Ang-2 induces vascular leakage in the lung vasculature without impacting kidney or liver vessels, thus directing metastasis to the lung. Exosomes released by the fibrotic organs also increase vascular permeability and metastatic colonization in the lung, without affecting kidney or liver vasculature. Single-cell RNAseq of fibrotic organs, as well as genetically engineered mice (GEMs), will be used to unravel the rate limiting effect of tissue-specific disruption of Ang-2 in breast cancer metastasis. Using novel GEMs generated in the lab, we will trace lineage-specific production of metastasis- inducing exosomes and identify the determinants of organotropism via proteomic analysis. Our preliminary studies show Ang-2 disrupts vascular barriers through repression of claudin-5 that is found exclusively in the lung vasculature, in contrast with the kidney and liver vessels, which present with multiple, redundant endothelial claudins. Integrating mouse models with endothelial-specific deletion of claudin-5 and claudin-5 reporter mice, and with molecular profiling of organ-specific endothelial cells in loss- and gain-of-function experiments, we will elucidate functions of specific claudins in organotropic metastasis. Molecular studies will be performed to identify putative mechanism of Ang-2 mediated suppression of claudin-5 and test whether manipulation of vascular permeability can re-route metastasis regardless of cancer-specific organ predilection. Successful completion of the proposed studies will provide new insights into mechanism of metastasis and therapeutic implications.
摘要 大多数患有实体瘤的癌症患者死于转移性疾病,向器官扩散是一个未充分研究的方面 转移,这迫切需要新的见解。流行的“种子和土壤”概念认为, 远处器官(土壤)中的容许环境对于支持潜伏肿瘤的存活和生长是必要的 种子(Seeds)提出在非转移性器官中诱导允许的污垢以改变转移的路线;然而, 缺乏严格的实验证据和机理分析。纤维化组织改变,包括 炎症,提供转移的线索,以及来自骨髓来源的细胞(BMDC)的信号, 肿瘤分泌体和循环细胞外囊泡。我们的初步数据表明向器官转移 不仅依赖于次级器官中允许的基质重塑和BMDC, 取决于器官特异性血管连接所施加的血管内皮屏障功能的破坏 proteins.我们的研究结果导致了一个中心假设,即“血管异质性在功能上有助于 向器官性转移我们提出研究来解开机制,通过不同的纤维化龛 影响血管床的器官特异性变化,导致向器官转移。初步研究 血管生成素-2(Ang-2)被认为是肺转移的介质。我们的目标是解开 Ang-2依赖于肺而不是肾或肝,肾或肝也在肺中产生高Ang-2水平。 纤维化环境。使用单细胞RNAseq和CyTOF,我们将确定细胞和分子靶点, 转移前环境中的Ang-2。初步研究表明Ang-2可诱导肺血管渗漏 在不影响肾或肝血管的情况下,将肿瘤转移至血管,从而引导转移至肺。外泌体释放 也增加肺中的血管通透性和转移性定植,而不影响 肾脏或肝脏脉管系统。纤维化器官的单细胞RNAseq以及基因工程小鼠 (GEMs),将被用来解开乳腺癌中Ang-2的组织特异性破坏的限速作用 转移使用实验室中产生的新型GEM,我们将追踪转移的谱系特异性产生- 诱导外泌体并通过蛋白质组学分析鉴定向器官性的决定因素。我们的初步 研究表明,血管紧张素-2通过抑制仅在肺中发现的claudin-5来破坏血管屏障 与肾脏和肝脏血管相比,肾脏和肝脏血管具有多个冗余的内皮细胞, claudins整合具有claudin-5和claudin-5报告小鼠的内皮特异性缺失的小鼠模型, 通过器官特异性内皮细胞功能丧失和获得实验的分子分析,我们将 阐明特定密封蛋白在向器官转移中的功能。将进行分子研究,以确定 Ang-2介导的claudin-5抑制的假定机制和测试是否操纵血管 渗透性可以改变转移的路线,而不管癌症特异性器官的偏好。成功完成 这些研究将为肿瘤转移机制和治疗提供新的思路。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RAGHU KALLURI其他文献

RAGHU KALLURI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RAGHU KALLURI', 18)}}的其他基金

Biology and Function of Exosomes in Cancer
外泌体在癌症中的生物学和功能
  • 批准号:
    10680453
  • 财政年份:
    2022
  • 资助金额:
    $ 51.01万
  • 项目类别:
Mechanisms associated with organotropic metastasis
与器官转移相关的机制
  • 批准号:
    10439900
  • 财政年份:
    2021
  • 资助金额:
    $ 51.01万
  • 项目类别:
Mechanisms associated with organotropic metastasis
与器官转移相关的机制
  • 批准号:
    10532826
  • 财政年份:
    2021
  • 资助金额:
    $ 51.01万
  • 项目类别:
Exosomes in Cancer Therapy
外泌体在癌症治疗中的应用
  • 批准号:
    9897907
  • 财政年份:
    2016
  • 资助金额:
    $ 51.01万
  • 项目类别:
Exosomes in Cancer Therapy
外泌体在癌症治疗中的应用
  • 批准号:
    10058770
  • 财政年份:
    2016
  • 资助金额:
    $ 51.01万
  • 项目类别:
Exosomes in Cancer Therapy
外泌体在癌症治疗中的应用
  • 批准号:
    9230198
  • 财政年份:
    2016
  • 资助金额:
    $ 51.01万
  • 项目类别:
Employing mouse models to translate early detection of pancreas cancer
利用小鼠模型转化胰腺癌的早期检测
  • 批准号:
    8904197
  • 财政年份:
    2015
  • 资助金额:
    $ 51.01万
  • 项目类别:
Employing mouse models to translate early detection of pancreas cancer
利用小鼠模型转化胰腺癌的早期检测
  • 批准号:
    9097660
  • 财政年份:
    2015
  • 资助金额:
    $ 51.01万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    8555539
  • 财政年份:
    2011
  • 资助金额:
    $ 51.01万
  • 项目类别:
Stromal Regulation of Bone Metastasis
骨转移的基质调节
  • 批准号:
    8505003
  • 财政年份:
    2011
  • 资助金额:
    $ 51.01万
  • 项目类别:

相似海外基金

A methodology to connect functionalized gonadal constructs to a chick embryo through mechanically induced blood vessels from an egg
一种通过鸡蛋机械诱导血管将功能化性腺结构连接到鸡胚胎的方法
  • 批准号:
    24K15741
  • 财政年份:
    2024
  • 资助金额:
    $ 51.01万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
All-in-One Smart Artificial Blood Vessels
一体化智能人造血管
  • 批准号:
    EP/X027171/2
  • 财政年份:
    2024
  • 资助金额:
    $ 51.01万
  • 项目类别:
    Fellowship
Development of nextgeneration cellular artificial blood vessels for coronary artery bypass surgery using bio-3D printer
使用生物 3D 打印机开发用于冠状动脉搭桥手术的下一代细胞人造血管
  • 批准号:
    23H02991
  • 财政年份:
    2023
  • 资助金额:
    $ 51.01万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Tissue engineered blood vessels
组织工程血管
  • 批准号:
    2891099
  • 财政年份:
    2023
  • 资助金额:
    $ 51.01万
  • 项目类别:
    Studentship
ealization of navigation surgery by automatic recognition of stomach and surrounding blood vessels using artificial intelligence
利用人工智能自动识别胃及周围血管,实现导航手术
  • 批准号:
    23K07176
  • 财政年份:
    2023
  • 资助金额:
    $ 51.01万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Realtime observation and optical control of living microbial probes in blood vessels
血管内活微生物探针的实时观察和光学控制
  • 批准号:
    23H00551
  • 财政年份:
    2023
  • 资助金额:
    $ 51.01万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Creation of a technique for visualization of stress concentration in blood and blood vessels by combined measurement of photoelasticity and ultrasonic Doppler velocimetry
通过光弹性和超声多普勒测速的组合测量,创建了一种可视化血管中应力集中的技术
  • 批准号:
    23H01343
  • 财政年份:
    2023
  • 资助金额:
    $ 51.01万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Shear stress-activated synthetic cells for targeted drug release in stenotic blood vessels
剪切应力激活合成细胞用于狭窄血管中的靶向药物释放
  • 批准号:
    10749217
  • 财政年份:
    2023
  • 资助金额:
    $ 51.01万
  • 项目类别:
Creation of 3D tissue culture system integrated with blood vessels and autonomic nerves
打造血管与植物神经融合的3D组织培养系统
  • 批准号:
    23H01827
  • 财政年份:
    2023
  • 资助金额:
    $ 51.01万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Biological function of osteoporotic drugs on bone-specific blood vessels and perivascular cells
骨质疏松药物对骨特异性血管和血管周围细胞的生物学功能
  • 批准号:
    22K21006
  • 财政年份:
    2022
  • 资助金额:
    $ 51.01万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了